Provisions relating to Offer for Sale of Shares Issued by Foreign Company Whose Shares Are Not Traded on Foreign Exchange

Granting the Purchasing Right to Provider of Over-Allotment Shares After Allotment of Shares in Excess of Underwriting Amount

transaction to invest in the common stock of BS Myco Biotech Company Limited that operate in the Biopharmaceutical products with purchase from Bangjak Green Energy Company Limited total 399,990 shares or 85.65

(Translation) No OCMSET/6106/002 June 12, 2018 Subject Increase of Registered Capital, Allocation and Offering of the Newly Issued Ordinary Shares to a Specific Investor (Private Placement), Application for

) June 12, 2018 Subject Increase of Registered Capital, Allocation and Offering of the Newly Issued Ordinary Shares to a Specific Investor (Private Placement), Application for Waiver from the Requirement

The Securities and Exchange Commission (SEC) invites public comments on proposed amendments to the regulations governing the reporting of initial public offering shares (IPO shares) results. These

Provisions relating to Offer for Sale of Shares Issued by Foreign Company of which Shares are not Traded in Foreign Exchange

Subject : Resolutions of the Board of Directors approving the capital decrease, the capital increase, the allotment of newly issued ordinary shares to investors in private placement, the acquisition of

June 12, 2018 Subject Increase of Registered Capital, Allocation and Offering of the Newly Issued Ordinary Shares to a Specific Investor (Private Placement), Application for Waiver from the Requirement

Application for Approval and Granting of Approval for Offering of Newly Issued Shares